|
1
|
Kelley JR and Duggan JM: Gastric cancer
epidemiology and risk factors. J Clin Epidemiol. 56:1–9. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jian P, Yanfang T, Zhuan Z, Jian W,
Xueming Z and Jian N: MMP28 (epilysin) as a novel promoter of
invasion and metastasis in gastric cancer. BMC Cancer. 11:2002011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao C, Xie R, Ren C and Yang X: Dickkopf-1
expression is a novel prognostic marker for gastric cancer. J
Biomed Biotechnol. 2012:8045922012.PubMed/NCBI
|
|
4
|
Kuhajda FP: Fatty acid synthase and
cancer: new application of an old pathway. Cancer Res.
66:5977–5980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuhajda FP, Jenner K, Wood FD, et al:
Fatty acid synthesis: a potential selective target for
antineoplastic therapy. Proc Natl Acad Sci USA. 91:6379–6383. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alo’ PL, Visca P, Marci A, Mangoni A,
Botti C and Di Tondo U: Expression of fatty acid synthase (FAS) as
a predictor of recurrence in stage I breast carcinoma patients.
Cancer. 77:474–482. 1996.PubMed/NCBI
|
|
7
|
Milgraum LZ, Witters LA, Pasternack GR and
Kuhajda FP: Enzymes of the fatty acid synthesis pathway are highly
expressed in in situ breast carcinoma. Clin Cancer Res.
3:2115–2120. 1997.PubMed/NCBI
|
|
8
|
Swinnen JV, Roskams T, Joniau S, et al:
Overexpression of fatty acid synthase is an early and common event
in the development of prostate cancer. Int J Cancer. 98:19–22.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ogino S, Nosho K, Meyerhardt JA, et al:
Cohort study of fatty acid synthase expression and patient survival
in colon cancer. J Clin Oncol. 26:5713–5720. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Orita H, Coulter J, Tully E, Kuhajda FP
and Gabrielson E: Inhibiting fatty acid synthase for
chemoprevention of chemically induced lung tumors. Clin Cancer Res.
14:2458–2464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sugino T, Baba K, Hoshi N, Aikawa K,
Yamaguchi O and Suzuki T: Overexpression of fatty acid synthase in
human urinary bladder cancer and combined expression of the
synthase and Ki-67 as a predictor of prognosis of cancer patients.
Med Mol Morphol. 44:146–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gansler TS, Hardman W III, Hunt DA,
Schaffel S and Hennigar RA: Increased expression of fatty acid
synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Hum Pathol. 28:686–692. 1997. View Article : Google Scholar
|
|
13
|
Kusakabe T, Nashimoto A, Honma K and
Suzuki T: Fatty acid synthase is highly expressed in carcinoma,
adenoma and in regenerative epithelium and intestinal metaplasia of
the stomach. Histopathology. 40:71–79. 2002. View Article : Google Scholar
|
|
14
|
Orita H, Coulter J, Tully E, et al: High
levels of fatty acid synthase expression in esophageal cancers
represent a potential target for therapy. Cancer Biol Ther.
10:549–554. 2010. View Article : Google Scholar
|
|
15
|
Pizer ES, Lax SF, Kuhajda FP, Pasternack
GR and Kurman RJ: Fatty acid synthase expression in endometrial
carcinoma: correlation with cell proliferation and hormone
receptors. Cancer. 83:528–537. 1998. View Article : Google Scholar
|
|
16
|
Sebastiani V, Visca P, Botti C, et al:
Fatty acid synthase is a marker of increased risk of recurrence in
endometrial carcinoma. Gynecol Oncol. 92:101–105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alo PL, Amini M, Piro F, et al:
Immunohistochemical expression and prognostic significance of fatty
acid synthase in pancreatic carcinoma. Anticancer Res.
27:2523–2527. 2007.PubMed/NCBI
|
|
18
|
Walter K, Hong SM, Nyhan S, et al: Serum
fatty acid synthase as a marker of pancreatic neoplasia. Cancer
Epidemiol Biomarkers Prev. 18:2380–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Horiguchi A, Asano T, Ito K, Sumitomo M
and Hayakawa M: Fatty acid synthase over expression is an indicator
of tumor aggressiveness and poor prognosis in renal cell carcinoma.
J Urol. 180:1137–1140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mashima T, Seimiya H and Tsuruo T: De novo
fatty-acid synthesis and related pathways as molecular targets for
cancer therapy. Br J Cancer. 100:1369–1372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rashid A, Pizer ES, Moga M, et al:
Elevated expression of fatty acid synthase and fatty acid synthetic
activity in colorectal neoplasia. Am J Pathol. 150:201–208.
1997.PubMed/NCBI
|
|
22
|
Piyathilake CJ, Frost AR, Manne U, et al:
The expression of fatty acid synthase (FASE) is an early event in
the development and progression of squamous cell carcinoma of the
lung. Hum Pathol. 31:1068–1073. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pizer ES, Pflug BR, Bova GS, Han WF, Udan
MS and Nelson JB: Increased fatty acid synthase as a therapeutic
target in androgen-independent prostate cancer progression.
Prostate. 47:102–110. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gabrielson EW, Pinn ML, Testa JR and
Kuhajda FP: Increased fatty acid synthase is a therapeutic target
in mesothelioma. Clin Cancer Res. 7:153–157. 2001.PubMed/NCBI
|
|
25
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Kuhajda FP, Li JN, et al: Fatty
acid synthase (FAS) expression in human breast cancer cell culture
supernatants and in breast cancer patients. Cancer Lett.
167:99–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vazquez-Martin A, Fernandez-Real JM,
Oliveras-Ferraros C, et al: Fatty acid synthase activity regulates
HER2 extracellular domain shedding into the circulation of
HER2-positive metastatic breast cancer patients. Int J Oncol.
35:1369–1376. 2009.
|
|
28
|
Wang Y, Kuhajda FP, Sokoll LJ and Chan DW:
Two-site ELISA for the quantitative determination of fatty acid
synthase. Clin Chim Acta. 304:107–115. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Notarnicola M, Tutino V, Calvani M,
Lorusso D, Guerra V and Caruso MG: Serum levels of fatty acid
synthase in colorectal cancer patients are associated with tumor
stage. J Gastrointest Cancer. 43:508–511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lukaszewicz-Zając M, Mroczko B, Gryko M,
Kędra B and Szmitkowski M: Comparison between clinical significance
of serum proinflammatory proteins (IL-6 and CRP) and classic tumor
markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med.
11:89–96. 2011.
|
|
31
|
Schneider J and Schulze G: Comparison of
tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen
(CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis
of gastrointestinal cancer. Anticancer Res. 23:5089–5093. 2003.
|
